Cheek filler study shows safety and aesthetic improvement
NCT ID NCT06565988
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested Decoria Voluma, a hyaluronic acid dermal filler, in 111 adults with midface volume deficit. The filler was injected into the cheeks to restore volume. Researchers measured aesthetic improvement using a standard scale and tracked side effects. The goal was to confirm the product's safety and performance in a real-world setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Decoria Voluma (hyaluronic acid dermal filler)
- What this could lead to
- If results are positive, this filler could offer a safe and effective option for restoring cheek volume.
- What could go wrong
- This is a post-market study, so the product is already on the market. Results may not apply to all patients, and side effects like injection reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIDFACE VOLUME DEFICIT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Florakliniken
Stockholm, 113 28, Sweden
-
Göteborgs Laser & Estetik
Gothenburg, 411 08, Sweden
-
Inskinity
Gothenburg, 411 07, Sweden
-
Inskinity
Stockholm, 111 28, Sweden
-
Svenska Hudkliniker
Karlstad, 652 25, Sweden
-
Svenska Hudkliniker
Stockholm, Sweden
-
The Faculty
Stockholm, 114 46, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.